Skip to content
DraconiticResearch
Search Sources API
211,646 studies31 sourcesUpdated 39 min ago

Oncology

5,331 studies510 in 7 days2,567 in 30 days

Filters
Type
Date
Clear

Latest

5,331 studies

  1. Combination of ALK2 and cholesterol targeting agents exploits linked genetic and metabolic dependencies in diffuse midline glioma
    R. Rogers, Y. Grabovska, A. Mackay +21
    bioRxivPreprintCC BYFull textOncologybioRxiv
  2. A Review of KSHV: Lifecycle, Tumorigenesis, Immune Evasion and Therapeutic Strategies.
    Chaoran Zhuo, Dongdong Cao, Fangling Li
    VirusesPeer-reviewedCC BYFull textOncologyEurope PMC
  3. Sophocarpine Inhibits Proliferation and Triggers Apoptosis in Breast Cancer Cells by Modulating the miR-21/PTEN/AKT and ERK1/2 Signaling Networks.
    Yasmin R Shahin, Nihal M Elguindy, Doaa A Ghareeb +2
    Pharmaceuticals (Basel, Switzerland)Peer-reviewedCC BYFull textOncologyEurope PMC
  4. Antiviral Sesquiterpene Lactones from Laurus nobilis L.: Inhibition of Hepatitis C Virus and Dengue Virus Replication.
    Yhiya Amen, Marwa Elsbaey, George Mpekoulis +5
    VirusesPeer-reviewedCC BYFull textOncologyEurope PMC
  5. Peripheral Blood Mononuclear Cell Expression Profile of Proliferation-, Ferroptosis-, and Immune-Related Targets in Breast Cancer.
    Rabia Demirtaş, Murat Kızılkaya, Eda Balkan +5
    Medicina (Kaunas, Lithuania)Peer-reviewedCC BYFull textOncologyEurope PMC
  6. Association of DNA Copy Number Aberrations with Organ-Specific Metastasis in Luminal B HER2-Negative Breast Cancer.
    Marina K Ibragimova, Matvey M Tsyganov, Arina K Shagabudinova +3
    Diseases (Basel, Switzerland)Peer-reviewedCC BYFull textOncologyEurope PMC
  7. Cancer Outcomes in Cardiovascular Trials of Inflammation-Targeting Therapeutics
    Laura I. Yousif, Wouter C. Meijers, Rudolf A. de Boer
    JACC: CardioOncologyPeer-reviewedCC BY-NC-ND 4.0Full textOncologyPMC
  8. CD3-engaging bispecific antibodies convert human regulatory T cells into cytotoxic effectors
    J. J. Michel, J. H. Frenking, A. Metzler +23
    medRxivPreprintAll rights reservedFull textOncologymedRxiv
  9. FRANK: a pan-cancer RNA-seq classifier for childhood tumors with data-efficient learning
    K. Sablauskas, T. Kiselova, L. Bardina +6
    medRxivPreprintCC BY-NC-NDFull textOncologymedRxiv
  10. Exploring the gut-brain axis in glioblastoma: a prospective case-control study of the gut bacteriome and mycobiome
    M. Herz, K. Schmid, M. Ankenbrand +12
    medRxivPreprintCC BYFull textOncologymedRxiv
  11. TILs in Breast Cancer: Paving New Ways Beyond Their Prognostic and Predictive Values.
    Jean-Marc Ferrero, Loïc Trapani, Rym Bouriga +3
    CancersPeer-reviewedCC BYFull textOncologyEurope PMC
  12. An Ex Vivo 3D Co-Culture Model of the Bone Marrow Niche Better Predicts Clinically Relevant Epigenetic Target Modulation to Improve Immunotherapy in Multiple Myeloma.
    Christine Greil, Johannes Jung, Julia Felthaus +3
    CancersPeer-reviewedCC BYFull textOncologyEurope PMC
  13. Preclinical-Clinical Discrepancies in Immune Checkpoint Inhibitor Efficacy for Triple-Negative Breast Cancer: Disease Stage, Antibody Properties, Biomarker Alignment, and Model Limitations.
    Yuwei Zhang, Hla Paing, Jing Wang
    CancersPeer-reviewedCC BYFull textOncologyEurope PMC
  14. Cystic Renal Masses: From Malignancy Probability to Risk-Adapted Management.
    Chencan Fang, Chenyi Ge, Lijuan Yin +9
    CancersPeer-reviewedCC BYFull textOncologyEurope PMC
  15. PD-L1 in Merkel Cell Carcinoma: From Tumor Microenvironment to Pathological Interpretation.
    Ludovica Pepe, Vincenzo Fiorentino, Mario Della Mura +5
    International journal of molecular sciencesPeer-reviewedCC BYFull textOncologyEurope PMC
  16. Association of PON2 and Its S311C Substitution with Tumor Progression and Its Significance as an Immune-Associated Prognostic Indicator in Clear Cell Renal Cell Carcinoma.
    Zhiyu Liu, Wei Yun, Ting Hong +5
    CancersPeer-reviewedCC BYFull textOncologyEurope PMC
  17. Minimally Invasive Surgical Approaches to Colorectal Cancer: Learning Curve and Cost Considerations.
    Aniket Maini, Benjamin P Gallant, Andrew Hu +1
    CancersPeer-reviewedCC BYFull textOncologyEurope PMC
  18. Transfer Learning-Based Quantification of Mitotic Activity and Its Prognostic and Molecular Associations in Lung Squamous Cell Carcinoma.
    Gulcin Yilmaz Gunes, Mehmet Akif Cifci
    CancersPeer-reviewedCC BYFull textOncologyEurope PMC
  19. Longitudinal Assessment of EGFR and MET Transcriptional Activity Using Cell-Free Chromatin Immunoprecipitation in Two Patients with EGFR-Mutated Non-Small Cell Lung Cancer.
    Emma Pedersen, Christoffer Trier Maansson, Peter Meldgaard +1
    CancersPeer-reviewedCC BYFull textOncologyEurope PMC
  20. Treatment Allocation and Survival Outcomes in Potentially Resectable Colorectal Liver Metastases: A Real-World Cohort Study from Thailand.
    Warakorn Jaseanchiun, Hiroyuki Kato, Chutima Phettool +9
    CancersPeer-reviewedCC BYFull textOncologyEurope PMC
  21. Bacteroides fragilis Toxin Induces Extracellular Domain Cleavage of HER2 in Intestinal Epithelial Cells.
    Sang-Hyeon Yoo, Ha-Neul Jang, Da-Hye Kang +4
    International journal of molecular sciencesPeer-reviewedCC BYFull textOncologyEurope PMC
  22. Why do reviewers disagree? Evidence from four funders and 134,000 reviews
    Jan-Ole Hesselberg, Pål Ulleberg, Øystein Sørensen +3
    PLOS OnePeer-reviewedCC BY 4.0Full textOncologyPLOS
  23. High-Dose Intravenous Vitamin C and Mistletoe Therapy in Breast Cancer: A Prospective Cohort Study on Overall Survival in Palliative Care
    Donghun Lee, Ha-Eun Ryu, Byoungjin Park +3
    CancersPeer-reviewedCC BYFull textOncologyEurope PMC
  24. Association of baseline hormone levels with outcomes of first-line immunotherapy in extensive-stage small cell lung cancer
    Shuxing Wang, Rui Meng, Jiheng Liu +17
    Translational Lung Cancer ResearchPeer-reviewedCC BY-NC-NDFull textOncologyEurope PMC
  25. Pharmacologically Targeting DHODH-Dependent Pyrimidine Metabolism with HSA-Conjugated BRQ Suppresses Leukemogenesis
    Xiaoxu Zhang, Changhao Tian, Yang Ding +4
    CancersPeer-reviewedCC BYFull textOncologyEurope PMC